Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 34Viral Infections and Immunology ResearchCOVID-19 Clinical Research StudiesKawasaki Disease and Coronary Complications

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Subacute and chronic post-covid myoendocarditis: clinical presentation, role of coronavirus persistence and autoimmune mechanisms

Open access
Blagova, O. V., Kogan, E. A., Lutokhina, Yu. A., Kukleva, A. D., Ainetdinova, D. H., Novosadov, V. M., Rud`, R. S., Zaitsev, A. Yu., Zaidenov, V. A., Kupriyanova, A. G., Alexandrova, S. А., Fomin, V. V.·2021·Kardiologiia

Abstract

Aim To study clinical features of myoendocarditis and its possible mechanisms, including persistence of SARS-Cov-2 in the myocardium, in the long-term period following COVID-19.Material and methods This cohort, prospective study included 15 patients aged 47.8±13.4 years (8 men) with post-COVID myocarditis. The COVID-19 diagnosis was confirmed for all patients. Median time to seeking medical care after COVID-19 was 4 [3; 7] months. The diagnosis of myocarditis was confirmed by magnetic resonance imaging (MRI) of the heart (n=10) and by endomyocardial biopsy of the right ventricle (n=6). The virus was detected in the myocardium with PCR; immunohistochemical (IHC) study with antibody to SARS-Cov-2 was performed; anticardiac antibody level was measured; and echocardiography and Holter monitoring were performed. Hemodynamically significant coronary atherosclerosis was excluded for all patients older than 40 years.Results All patients showed a clear connection between the emergence or exacerbation of cardiac symptoms and COVID-19. 11 patients did not have any signs of heart disease before COVID-19; 4 patients had previously had moderate arrhythmia or heart failure (HF) without myocarditis. Symptoms of myocarditis emerged at 1–5 months following COVID-19. MRI revealed typical late gadolinium accumulation, signs of hyperemia, and one case of edema. The level of anticardiac antibodies was increased 3-4 times in 73 % больных. Two major clinical variants of post-COVID myocarditis were observed. 1. Arrhythmic (n=6), with newly developed extrasystole or atrial fibrillation without systolic dysfunction. 2. Decompensated variant with systolic dysfunction and biventricular HF (n=9). Mean left ventricular ejection fraction was 34.1±7.8 %, and left ventricular end-diastolic dimension was 5.8±0.7 cm. In one case, myocarditis was associated with signs of IgG4‑negative aortitis. SARS-Cov-2 RNA was found in 5 of 6 biopsy samples of the myocardium. The longest duration of SARS-Cov-2 persistence in the myocardium was 9 months following COVID-19. By using antibody to the Spike antigen and nucleocapsid, SARS-Cov-2 was detected in cardiomyocytes, endothelium, and macrophages. Five patients were diagnosed with lymphocytic myocarditis; one with giant-cell myocarditis; three patients had signs of endocarditis (infectious, lymphocytic with mural thrombosis).Conclusion Subacute/chronic post-COVID myocarditis with isolated arrhythmias or systolic dysfunction is characterized by long-term (up to 9 months) persistence of SARS-Cov-2 in the myocardium in combination with a high immune activity. Endocarditis can manifest either as infectious or as nonbacterial thromboendocarditis. A possibility of using corticosteroids and anticoagulants in the treatment of post-COVID myoendocarditis should be studied.

Overview

Integrity signals

Registry

Crossref · 10.18087/cardio.2021.6.n1659

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Tyrin V.P. Infective endocarditis. 2nd edition, expanded and revised. -M.: GEOTAR-Media;2013. - 368 p. ISBN 978-5-9704-2080-5

Cited by

See all 34

Metadata

Authors
Blagova, O. V., Kogan, E. A., Lutokhina, Y. A., Kukleva, A. D., Ainetdinova, D. H., Novosadov, V. M., Rud`, R. S., Zaitsev, A. Y., Zaidenov, V. A., Kupriyanova, A. G., Alexandrova, S. А., & Fomin, V. V.
Affiliations
  • Sechenov University (RU)
  • The State Education Institution of Higher Professional Training the First I.M. Sechenov Moscow State Medical University (Sechenov University), Moscow, Russia
  • City Clinical Hospital № 52, Moscow, Russia
  • Moscow Regional Scientific Research Clinical Institute. MF Vladimirsky (RU)
  • Bakulev Scientific Center for Cardiovascular Surgery Russian Academy of Medical Sciences (RU)
Venue
Kardiologiia
Published
2021-07-01
Volume
61
Issue
6
Pages
11-27
ISSN
  • 0022-9040 (ISSN-L)
  • 2412-5660
OpenAlex
W3186356897
Cited by
34
References
40
Citations by year
2026: 2 · 2025: 4 · 2024: 3 · 2023: 13 · 2022: 11 · 2021: 1
FWCI
4.69
Type
journal article
Language
ru
Open access
Locations
  • Kardiologiia (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Kawasaki Disease and Coronary Complications
Keywords
autoimmune mechanisms, cardiac arrhythmias, heart failure with reduced ejection fraction, long COVID, myocarditis, late gadolinium enhancement, endomyocardial biopsy, SARS-CoV-2 RNA
MeSH terms
COVID-19, SARS-CoV-2, COVID-19 Testing, Atrial Fibrillation, Humans, Male, Myocarditis, Myocardium, Prospective Studies, RNA, Viral, Stroke Volume, Ventricular Function, Left, Myocytes, Cardiac

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.